Seven candidates are vying for the five seats that are up for grabs this November. Here's a look at each of them.

Elicera Therapeutics describes how CAR T cells armed with neutrophil-activatingprotein can improve cancer therapy by inducing ...

The company plans to use the Series B investment to advance the development of its macrophage therapies in inflammatory and ...

Resolution Therapeutics Ltd. is preparing for a phase I/II trial of its autologous engineered macrophage cell therapy, RTX-001, in the treatment of end-stage liver disease and has raised £63.5 million ...

B-cell activating factor receptor (BAFF-R) chimeric antigen receptor (CAR) T-cell therapy incited cytotoxic effects on both ...

Here’s a round-up of crime news from across B.C. on Oct. 3, 2024. Package containing meth, cell phones seized at Matsqui ...

Cynthia Butler’s anger evolved into activism after Amanda Lane died at the Mabel Bassett Correctional Center in February 2022 ...

We recently compiled a list of the 7 Best Rising Penny Stocks To Invest In Now. In this article, we are going to take a look ...

Several of the new FCEVs are anticipated to support J.B. Hunt Intermodal operations in California and will primarily be used ...

New investors Pfizer Ventures and M Ventures co-led the financing, with participation from all existing investors including RA Capital, Samsara ...

Find out about Resolution Therapeutics' macrophage therapy, as it just raised $85 million in a series B round.

A sublingual formulation of cladribine showed comparable pharmacological properties to its name brand counterpart, Mavenclad.